Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kim Laboratories is a biotechnology company specializing in the development of novel solutions for food safety and infectious disease management. The company leverages two primary technology platforms: bacteriophage therapy and avian egg yolk antibodies (IgY) to target enteric pathogens such as Listeria, Salmonella, and E. coli. Their research extends to both diagnostic applications for rapid pathogen detection and therapeutic interventions to prevent or treat infections. Based in Champaign, Illinois, Kim Laboratories aims to provide natural, non-antibiotic alternatives for controlling harmful bacteria in the food supply chain and clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kim Laboratories.